Cofstop-A Syrup
By Cofstop-A
Rx
100ml Syrup in a Bottle

Composition
Ambroxol(15mg/5ml) + Guaifenesin(50mg/5ml) + Menthol(2.5mg/5ml) + Terbutaline(1.25mg/5ml)

Manufacturer - Apex Laboratories Pvt Ltd
III Floor SIDCO Garment Complex, Guindy, Chennai 600 032, India

Expires on or after
January, 2026

liver
Cofstop-A Syrup is considered safe for use in individuals with liver disease. Based on the limited data available, it appears that there may not be a need for dose adjustment of Cofstop-A Syrup in patients with liver issues. It is advisable to seek guidance from your doctor before using this syrup, especially if you have concerns regarding your liver health.

kidney
Cofstop-A Syrup is likely safe for use in patients with kidney disease. Available data indicates that adjusting the dose may not be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Cofstop-A Syrup.

driving
It is not clear if Cofstop-A Syrup affects driving ability. Refrain from driving if you have symptoms that disrupt focus and reaction times.

pregnancy
Cofstop-A Syrup is not recommended during pregnancy due to limited human studies, but animal studies suggest harm to the baby. Consult your doctor for a full evaluation of benefits and risks before using.

breastfeeding
It is better to consult your doctor before using Cofstop-A Syrup during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹84.9
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024